Spire Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $102K | Sell |
|
|||||
|
2025
Q2 | $108K | Buy |
|
|||||
|
2025
Q1 | $56.8K | Sell |
|
|||||
|
2024
Q4 | $77.5K | Buy |
|
|||||
|
2024
Q3 | $22.9K | Sell |
|
|||||
|
2024
Q2 | $27.2K | Sell |
|
|||||
|
2024
Q1 | $216K | Buy |
|
|||||
|
2023
Q4 | $28.1K | Sell |
|
|||||
|
2023
Q3 | $47.8K | Buy |
|
|||||
|
2023
Q2 | $44.5K | Buy |
|
|||||
|
2023
Q1 | $17.8K | Buy |
|
|||||
|
2022
Q4 | $15K | Hold |
|
|||||
|
2022
Q3 | $24K | Hold |
|
|||||
|
2022
Q2 | $23K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $83K | Buy |
|
|||||
|
2021
Q3 | $11K | Hold |
|
|||||
|
2021
Q2 | $16K | Sell |
|
|||||
|
2021
Q1 | $44K | Buy |
|